Topic
Astrazeneca
Recent coverage of Astrazeneca from across the web.
-
An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’
-
AstraZeneca slides after report of Bristol Myers merger talks leaves analysts 'perplexed' -
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports - AstraZeneca immune from Covid-19 vaccine injury lawsuit
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow